Skip to main content

Table 1 Baseline demographics

From: Impact of a novel protocol for atrial fibrillation management in outpatient gastrointestinal endoscopic procedures: a retrospective cohort study

Characteristics Group 1 (Pre-Intervention) Group 2 (Intervention) p-value
(n = 109) (n = 141)
Age, years 70 ± 9 72 ± 9 0.25
Female 32 (29%) 37 (26%) 0.586
Hypertension 80 (73%) 109 (77%) 0.48
Diabetes 30 (28%) 43 (31%) 0.61
EF < 40% 6 (6%) 6 (4%) 0.648
History of stroke 19 (17%) 16 (11%) 0.17
CAD/PVD 25 (23%) 38 (27%) 0.47
New AF Diagnosis, n (%) 8 (7%) 15 (11%) 0.37
Mean CHA2DS2VASc in all patients 2.99 3.05 0.78
Mean CHA2DS2VASc in new AF patients 2.00 3.27 0.09
Average SBP 128 129 0.53
Average DBP 72 72 0.88
Average HR 76 74 0.32
  1. AF atrial fibrillation, CAD coronary artery disease, CHA2DS2VASc congestive heart failure, hypertension, age, diabetes, stroke/transient ischemic attack/thromboembolism, vascular disease, age 65–75 years, sex category, EF ejection fraction, PVD peripheral vascular disease, HR heart rate, SBP systolic blood pressure, DBP diastolic blood pressure. Values are mean ± standard deviation for continuous data and n (%) for categorical data